These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3906559)

  • 1. Cisplatin: synthesis, antitumour activity and mechanism of action.
    Reedijk J; Lohman PH
    Pharm Weekbl Sci; 1985 Oct; 7(5):173-80. PubMed ID: 3906559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts.
    Comess KM; Burstyn JN; Essigmann JM; Lippard SJ
    Biochemistry; 1992 Apr; 31(16):3975-90. PubMed ID: 1314653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.
    Fichtinger-Schepman AM; van der Veer JL; den Hartog JH; Lohman PH; Reedijk J
    Biochemistry; 1985 Jan; 24(3):707-13. PubMed ID: 4039603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques.
    Plooy AC; Fichtinger-Schepman AM; Schutte HH; van Dijk M; Lohman PH
    Carcinogenesis; 1985 Apr; 6(4):561-6. PubMed ID: 4039227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents.
    Hollis LS; Sundquist WI; Burstyn JN; Heiger-Bernays WJ; Bellon SF; Ahmed KJ; Amundsen AR; Stern EW; Lippard SJ
    Cancer Res; 1991 Apr; 51(7):1866-75. PubMed ID: 2004370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymerization by DNA polymerase eta is blocked by cis-diamminedichloroplatinum(II) 1,3-d(GpTpG) cross-link: implications for cytotoxic effects in nucleotide excision repair-negative tumor cells.
    Chijiwa S; Masutani C; Hanaoka F; Iwai S; Kuraoka I
    Carcinogenesis; 2010 Mar; 31(3):388-93. PubMed ID: 20015866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro.
    Shellard SA; Hosking LK; Hill BT
    Cancer Res; 1991 Sep; 51(17):4557-64. PubMed ID: 1873800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Basis for Human DNA Polymerase Kappa to Bypass Cisplatin Intrastrand Cross-Link (Pt-GG) Lesion as an Efficient and Accurate Extender.
    Jha V; Ling H
    J Mol Biol; 2018 May; 430(11):1577-1589. PubMed ID: 29715472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II).
    Plooy AC; van Dijk M; Berends F; Lohman PH
    Cancer Res; 1985 Sep; 45(9):4178-84. PubMed ID: 3928152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-protein cross-linking in L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II).
    Olinski R; Briggs RC
    Mol Biol Rep; 1991 May; 15(2):81-6. PubMed ID: 1749377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The formation and repair of cisplatin-DNA adducts in wild-type and cisplatin-resistant L1210 cells: comparison of immunocytochemical determination with detection in isolated DNA.
    Blommaert FA; Floot BG; van Dijk-Knijnenburg HC; Berends F; Baan RA; Schornagel JH; den Engelse L; Fichtinger-Schepman AM
    Chem Biol Interact; 1998 Jan; 108(3):209-25. PubMed ID: 9528691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation and repair of cisplatin-induced adducts to DNA in cultured normal and repair-deficient human fibroblasts.
    Dijt FJ; Fichtinger-Schepman AM; Berends F; Reedijk J
    Cancer Res; 1988 Nov; 48(21):6058-62. PubMed ID: 3167856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-ray structure of the major adduct of the anticancer drug cisplatin with DNA: cis-[Pt(NH3)2(d(pGpG))].
    Sherman SE; Gibson D; Wang AH; Lippard SJ
    Science; 1985 Oct; 230(4724):412-7. PubMed ID: 4048939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin.
    Donahue BA; Augot M; Bellon SF; Treiber DK; Toney JH; Lippard SJ; Essigmann JM
    Biochemistry; 1990 Jun; 29(24):5872-80. PubMed ID: 2383564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities.
    Trimmer EE; Zamble DB; Lippard SJ; Essigmann JM
    Biochemistry; 1998 Jan; 37(1):352-62. PubMed ID: 9425057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of cis-dichlorodiammineplatinum(II).
    Zwelling LA; Kohn KW
    Cancer Treat Rep; 1979; 63(9-10):1439-44. PubMed ID: 387221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical and biological studies of the major DNA adduct of cis-diamminedichloroplatinum(II), cis-[Pt(NH3)2(d(GpG]], built into a specific site in a viral genome.
    Naser LJ; Pinto AL; Lippard SJ; Essigmann JM
    Biochemistry; 1988 Jun; 27(12):4357-67. PubMed ID: 3166983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of DNA adducts of antitumour cis-diamminedichloroplatinum(II). Immunochemical analysis.
    Vrána O; Kiseleva VI; Poverenny AM; Brabec V
    Eur J Pharmacol; 1992 May; 226(1):5-13. PubMed ID: 1397055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin.
    Pil PM; Lippard SJ
    Science; 1992 Apr; 256(5054):234-7. PubMed ID: 1566071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
    Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
    Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.